13:48 Uhr
AKTIE IM FOKUS 2: Fresenius-​Aktionäre fürchten teuren Rechtsstreit mit Akorn

WEISSLAW LLP: Mead Johnson Nutrition Company Acquisition May Not Be in the Best Interests of MJN Shareholders

Dienstag, 14.02.2017 23:40 von PR Newswire

PR Newswire

NEW YORK, Feb. 14, 2017 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Mead Johnson Nutrition Company (NYSE: MJN) ("MJN" or the "Company") in connection with the proposed acquisition of the Company by Britain's Reckitt Benckiser Group Plc.("Reckitt Benckiser") for $17.9 billion, inclusive of debt. Under the terms of the agreement, the Company's shareholders will receive $90.00 in cash for each MJN share they own.

WeissLaw is investigating whether MJN's Board acted to maximize shareholder value prior to entering into the agreement. Notably, at least one analyst set a target price of $95.00 per share, or $5.00 above the offer price. Additionally, the per-share consideration is also $4.40 lower than the Company's 52-week high of $94.40. Finally, the deal doubles the size of Reckitt Benckiser's consumer health segment and increases its exposure in emerging markets. This will provide significant relief for Reckitt Benckiser, which has experienced a recent slow-down in growth. It recently announced 3% revenue growth for 2016, its weakest report in over a decade. The deal offers Reckitt Benckiser solid opportunities for growth, and it anticipates double-digit percentage growth in earnings per-share after closing. 

Given these facts, WeissLaw is investigating whether MJN's Board acted in the best interests of MJN's public shareholders to maximize shareholder value prior to entering into the agreement. If you own MJN shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at  

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at or fill out the form on our website,


To view the original version on PR Newswire, visit: